Associations Between Self-Rated Health and Mortality in the Norwegian Women and Cancer (NOWAC) Study
Ida Killie,Tonje Braaten,Geir Lorem,Kristin Benjaminsen Borch
DOI: https://doi.org/10.2147/clep.s433965
2024-02-20
Clinical Epidemiology
Abstract:Ida Løken Killie, 1 Tonje Braaten, 1 Geir Fagerjord Lorem, 2 Kristin Benjaminsen Borch 1 1 Department of Community Medicine, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway; 2 Department of Psychology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway Correspondence: Ida Løken Killie, Department of Community Medicine, Faculty of Health Sciences, UiT Arctic University of Norway, Breivika, Tromsø, 9037, Norway, Tel +47 776 25199, Email Purpose: We investigated the association between self-rated health (SRH) and cancer incidence and SRH and all-cause mortality among Norwegian women. Population and Methods: We used data from 110,104 women in the Norwegian Women and Cancer (NOWAC) cohort aged 41– 70 years at baseline. We used flexible parametric survival analysis with restricted cubic splines to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between SRH and mortality in the entire cohort. We employed the same method in a multistate design to assess associations between baseline SRH and 1) cancer incidence, and 2) all-cause mortality in subgroups of women who did and did not receive a cancer diagnosis during follow-up. Results: With very good SRH as reference category for all associations and median age at end of follow-up, lower SRH was associated with increased mortality (HR good SRH 1.19, 95% CI 1.12– 1.26) and HR poor SRH 1.81, 95% CI 1.66– 1.97). Lower SRH at baseline was associated with cancer incidence (HR good SRH 1.14, 95% CI 1.08– 1.20 and HR poor SRH 1.44, 95% CI: 1.32– 1.58). Poor baseline SRH was associated with increased mortality for women who received a cancer diagnosis (HR poor SRH 1.20, 95% CI 1.04– 1.39), and SRH showed a strong association with increased mortality for women who stayed cancer free (HR good SRH 1.59, 95% CI 1.44– 1.77 and HR poor SRH 3.34, 95% CI 2.91– 3.84). Conclusion: Lower SRH at baseline predicted increased cancer risk and all-cause mortality in middle-aged to older women. Poor SRH at baseline predicted all-cause mortality in women who later received a cancer diagnosis. Both good and poor SRH at baseline predicted all-cause mortality in women who stayed cancer-free, and the association was stronger for these women compared to both the entire cohort and to women who were subsequently diagnosed with cancer. Keywords: self-rated health, cohort study, multistate, cancer, mortality, women Despite improved diagnostic methods, screening, and treatment for the most prevalent cancer types, the overall burden of cancer is rising worldwide due to increased incidence and life expectancy, 1 making the health and quality of life of cancer survivors a public health issue that requires attention and research. Improved prevention and risk reduction are crucial to further reduce morbidity, mortality, and other cancer-related health challenges faced by these survivors. Several prospective, population-based studies have shown that self-rated health (SRH) predicts all-cause mortality, independent of other risk factors. 2–4 SRH is a measure commonly used in population-based surveys; participants usually rank it on a four- or five-point scale based on their perceived overall health. The underlying mechanisms by which SRH predicts mortality are not well understood, but SRH correlates well with general health status and may incorporate information that is not easily measured or quantified, such as psychosocial conditions, underlying physical conditions and coping abilities, objective health information, symptoms, and health-related behavior. 5,6 A recent study using data from the UK Biobank study found that cross-matched poor SRH and unfavorable health status derived from patient journals were associated with increased mortality risk, with similar effect estimates as those calculated from studies on SRH and mortality. 7 SRH is a straightforward and short question to pose to a patient in a clinical setting. Given its inclusive content, we believe SRH could be used clinically for health assessment, risk assessment, and monitoring of patients undergoing cancer treatment. The prospective design of the Norwegian Women and Cancer (NOWAC) study and its linkage to the Cancer Registry of Norway and the Norwegian Cause of Death Registry allow researchers to study the ability of pre-diagnostic SRH to predict mortality among women who receive a cancer diagnosis during follow-up. Nabulsi et al found that low pre-diagnostic SRH was associated with a moderate increase in all-cause mortality in a retrospective cohort study of patients with multiple myeloma. -Abstract Truncated-
public, environmental & occupational health